Intuniv
Showing 26 - 38 of 38
ADHD Trial in New Haven (Mindfulness-Based ADHD Treatment for Children, Goal-Standard Medication (Treatment as Usual))
Recruiting
- Attention Deficit Hyperactivity Disorder
- Mindfulness-Based ADHD Treatment for Children
- Goal-Standard Medication (Treatment as Usual)
-
New Haven, ConnecticutClinical & Affective Neuroscience Lab
Jun 14, 2022
Intermittent Explosive Disorder, Childhood Aggression, Oppositional Defiant Disorder Trial in New York (behavioral, other, drug)
Completed
- Intermittent Explosive Disorder
- +3 more
- Parent Management Training
- +2 more
-
New York, New YorkNew York State Psychiatric Institute
Jun 11, 2018
Alcohol Abstinence Trial in East Setauket, Stony Brook (Guanfacine XR 3mgs/daily, Placebo (for guanfacine))
Recruiting
- Alcohol Abstinence
- Guanfacine XR 3mgs/daily
- Placebo (for guanfacine)
-
East Setauket, New York
- +1 more
Sep 4, 2018
ADHD (ADHD) Trial in Montreal (Methylphenidate compounds and /or Amphetamine compounds and/or Strattera or Guanfacine, Aerobic
Unknown status
- Attention Deficit Hyperactivity Disorder (ADHD)
- Methylphenidate compounds and /or Amphetamine compounds and/or Strattera or Guanfacine
- Aerobic Exercise
-
Montreal, Quebec, CanadaMontreal Children's Hospital
Aug 13, 2018
ADHD, Autism Spectrum Disorder Trial in Canada, United States (Randomization to either Amphetamine (AMP) class of stimulant
Not yet recruiting
- ADHD
- Autism Spectrum Disorder
- Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication
- Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
-
Irvine, California
- +11 more
Jun 14, 2023
ADHD, ADHD Trial in New York (Guanfacine Hydrochloride XR, Placebo)
Completed
- ADHD
- Attention Deficit Hyperactivity Disorder
- Guanfacine Hydrochloride XR
- Placebo
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Jan 17, 2018
ADHD, Reading Disabilities Trial in Cincinnati, Houston (Methylphenidate, Intensive reading instruction, Parent Training)
Completed
- Attention Deficit Hyperactivity Disorder
- Reading Disabilities
- Methylphenidate
- +5 more
-
Cincinnati, Ohio
- +1 more
Feb 27, 2017
ADHD Trial in Ottawa (Guanfacine extended release, Placebo, Stimulant therapy)
Completed
- Attention Deficit Hyperactivity Disorder
- Guanfacine extended release
- +2 more
-
Ottawa, Ontario, CanadaJPM van Stralen Medicine Professional Corporation
May 15, 2016
Adult Attention-Deficit Hyperactivity Disorder Trial in Rochester Hills (Guanfacine Hydrocholride)
Completed
- Adult Attention-Deficit Hyperactivity Disorder
- Guanfacine Hydrocholride
-
Rochester Hills, MichiganRochester Center for Behavioral Medicine
Dec 2, 2014
ADHD Trial in Cary (extended release guanfacine)
Completed
- Attention Deficit Hyperactivity Disorder
- extended release guanfacine
-
Cary, North Carolina3C Family Services
Jul 25, 2014
Attention-Deficit/Hyperactivity Disorder, Attention Deficit Disorder, Insomnia Trial in Hamilton, Toms River (Guanfacine
Terminated
- Attention-Deficit/Hyperactivity Disorder
- +3 more
- Guanfacine extended-release tablets
- Placebo comparator
-
Hamilton, New Jersey
- +1 more
Jul 21, 2014
Attention-deficit/Hyperactivity Disorder Trial in Ridgewood (Guanfacine (sustained release))
Completed
- Attention-deficit/Hyperactivity Disorder
- Guanfacine (sustained release)
-
Ridgewood, New JerseyNeurology Group of Bergen County
Apr 1, 2014
Attention Deficit Disorder With Hyperactivity Trial in San Antonio (Guanfacine Extended Release, Placebo)
Completed
- Attention Deficit Disorder With Hyperactivity
- Guanfacine Extended Release
- Placebo
-
San Antonio, TexasDept. Of Psychiatry, University of Texas Health Science Center a
Aug 1, 2012